Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency
European Commission decision anticipated in July BOSTON, May 21, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals,…